We are live on ! Find out more
CDH

Charles D. Hyman Portfolio holdings

AUM $1.79B
1-Year Est. Return 17.18%
This Fund
S&P 500
This Quarter Est. Return
+4.03%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$632M
AUM Growth
+$25.9M
Cap. Flow
+$5.33M
Cap. Flow %
0.84%
Top 10 Hldgs %
30.59%
Holding
149
New
4
Increased
55
Reduced
53
Closed
10

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.02M
2
BA icon
Boeing
BA
+$895K
3
JNJ icon
Johnson & Johnson
JNJ
+$755K
4
LMT icon
Lockheed Martin
LMT
+$669K
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$642K

Top Sells

Rank Stock Value
1
VBR icon
Vanguard Small-Cap Value ETF
VBR
+$362K
2
IBM icon
IBM
IBM
+$351K
3
GLD icon
SPDR Gold Trust
GLD
+$276K
4
CVX icon
Chevron
CVX
+$267K
5
APD icon
Air Products & Chemicals
APD
+$248K

Sector Composition

Rank Sector Weight
1 Industrials 19.37%
2 Consumer Staples 11.75%
3 Healthcare 10.73%
4 Financials 8.98%
5 Energy 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
POT
126
DELISTED
Potash Corp Of Saskatchewan
POT
$264K 0.04%
15,500
-100
-0.6% -$1.68K
SPY icon
127
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$247K 0.04%
1,201
– –
AMLP icon
128
Alerian MLP ETF
AMLP
$13B
$246K 0.04%
4,500
– –
K
129
DELISTED
Kellanova
K
$237K 0.04%
3,302
– –
TXN icon
130
Texas Instruments
TXN
$255B
$230K 0.04%
4,006
-100
-2% -$5.31K
ED icon
131
Consolidated Edison
ED
$41.6B
$224K 0.04%
+2,920
New +$207K
NVIV
132
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$224K 0.04%
+2
New +$215K
VLY icon
133
Valley National Bancorp
VLY
$7.93B
$221K 0.04%
+23,132
New +$210K
AFL icon
134
Aflac
AFL
$63.9B
$220K 0.03%
6,984
-176
-2% -$5.23K
OPK icon
135
Opko Health
OPK
$921M
$188K 0.03%
18,119
– –
NCV
136
Virtus Convertible & Income Fund
NCV
$374M
$74K 0.01%
3,350
-467
-12% -$9.45K
GNMX
137
DELISTED
Aevi Genomic Medicine Inc
GNMX
$67K 0.01%
15,143
– –
NWBO
138
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$66K 0.01%
45,375
– –
SONN
139
DELISTED
Sonnet BioTherapeutics
SONN
– –
0
– –
ANR
140
DELISTED
Alpha Natural Resources Inc
ANR
– –
-15,500
Closed –
CNB
141
DELISTED
COLONIAL BANCGROUP INC
CNB
– –
-27,979
Closed –
2 3 4 5
6

Similar funds

AT
Arvest Trust Bartlesville, Oklahoma $1.68B AUM 14.24% 1-Year Est. Return
BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
LFDLE
La Financiere de L'Echiquier Paris, France $2.29B AUM 37.29% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Charles D. Hyman's Q1 2016 Portfolio in Review

As of Q1 2016, Charles D. Hyman held 149 positions worth $632M, up 4.3% from $606M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Charles D. Hyman's Q1 2016 filing shows 4 new, 55 increased, 53 reduced and 10 closed positions. Its largest new stake was Regency Centers: 7,972 shares worth $597K. The largest sale was Vanguard Small-Cap Value ETF, an estimated $362K.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Charles D. Hyman's largest Q1 2016 buy was Regency Centers: 7,972 shares worth $597K.
  • Charles D. Hyman added most to Apple in Q1 2016, an estimated $1.02M increase.
  • Charles D. Hyman's biggest Q1 2016 reduction was Vanguard Small-Cap Value ETF, cutting an estimated $362K.
  • Charles D. Hyman fully exited COLONIAL BANCGROUP INC in Q1 2016, selling an estimated $0.
  • Charles D. Hyman's ten largest holdings make up 31% of its $632M portfolio in Q1 2016.
  • Charles D. Hyman opened 4 new positions and closed 10 in Q1 2016.
  • Charles D. Hyman's portfolio value rose 4.3% quarter-over-quarter to $632M.

Based on Charles D. Hyman's 13F filing for Q1 2016, filed 3 May 2016.